ActivePhase 2ACTRN12607000448448

A Phase 2 Two-Center, Randomized, Double-blind, Placebo-controlled, Paired Treatment Site Comparison Study to Evaluate the Safety and Preliminary Efficacy of a Topical Antimicrobial (NEO101) in Reduction of Wound Bioburden among Adults Treated with Curettage & Electrodessication for Superficial Basal Cell Carcinomas of the Trunk and Extremities

Sponsor

Neosil Inc.

Enrollment

15 participants

Start Date

Sep 10, 2007

Study Type

Interventional

Conditions

Antimicrobial treatment of wounds

Summary

The Skin Centre Suite 5 AHC House 14 Carrara Street Benowa, Queensland 4217 Southeast Dermatology 1202 Creek Road Carina Heights, Queensland 4152 Therapeutics Goods Administration CTN Number 2007/487

Eligibility

Sex: Both males and femalesMin Age: 30 YearssMax Age: 80 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests a topical antimicrobial cream (NEO101) for reducing bacteria in wounds after treatment for superficial basal cell skin cancer. It is open to adults aged 30 to 80 who have had curettage and electrodesiccation for basal cell carcinoma. Participants will apply the cream to treated wound sites and have bacterial levels monitored.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Eligible subjects will be randomized to receive both NEO101 0.95% gel and vehicle-containing placebo gel. Treatment (blinded to treatment assignment) will be administered to paired target surface are

Eligible subjects will be randomized to receive both NEO101 0.95% gel and vehicle-containing placebo gel. Treatment (blinded to treatment assignment) will be administered to paired target surface areas twice daily for 7 days. A 14-day safety and efficacy assessment period will follow the treatment period.

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12607000448448